RPS15 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.664200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.962800E-01
Normal-vs-Stage2
5.054400E-01
Normal-vs-Stage3
9.992800E-01
Normal-vs-Stage4
5.708600E-01
Stage1-vs-Stage2
5.780000E-01
Stage1-vs-Stage3
4.442800E-01
Stage1-vs-Stage4
7.073400E-01
Stage2-vs-Stage3
4.441200E-01
Stage2-vs-Stage4
9.070400E-01
Stage3-vs-Stage4
5.633200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.200200E-01
Normal-vs-AfricanAmerican
9.610400E-01
Normal-vs-Asian
4.265600E-01
Caucasian-vs-AfricanAmerican
2.307600E-01
Caucasian-vs-Asian
3.344400E-01
AfricanAmerican-vs-Asian
1.403840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.456400E-01
Normal-vs-Female
5.094200E-01
Male-vs-Female
2.405000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.458800E-01
Normal-vs-Age(41-60Yrs)
5.846000E-01
Normal-vs-Age(61-80Yrs)
4.718600E-01
Normal-vs-Age(81-100Yrs)
2.020600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.852400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.582800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.936800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.111970E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.367850E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.372800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.276200E-01
Normal-vs-Daily Drinker
2.607400E-01
Normal-vs-Weekly Drinker
4.419600E-01
Normal-vs-Occasional Drinker
4.196400E-01
Normal-vs-Social Drinker
5.921800E-01
Non Drinker-vs-Daily Drinker
2.621200E-01
Non Drinker-vs-Weekly Drinker
3.685400E-01
Non Drinker-vs-Occasional Drinker
8.902800E-01
Non Drinker-vs-Social Drinker
5.549800E-01
Daily Drinker-vs-Weekly Drinker
7.229200E-01
Daily Drinker-vs-Occasional Drinker
3.978800E-01
Daily Drinker-vs-Social Drinker
1.513380E-01
Weekly Drinker-vs-Occasional Drinker
4.158200E-01
Weekly Drinker-vs-Social Drinker
2.513800E-01
Occasional Drinker-vs-Social Drinker
5.133800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.596400E-01
Normal-vs-Grade 2
8.663800E-01
Normal-vs-Grade 3
8.120800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.270800E-01
Grade 1-vs-Grade 3
3.940400E-01
Grade 1-vs-Grade 4
9.596400E-01
Grade 2-vs-Grade 3
7.136800E-01
Grade 2-vs-Grade 4
8.663800E-01
Grade 3-vs-Grade 4
8.120800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.798000E-01
Normal-vs-NonDiabetic
3.879600E-01
Diabetic-vs-NonDiabetic
8.949000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.799400E-01
Normal-vs-NoPancreatitis
4.196000E-01
Pancreatitis-vs-NoPancreatitis
8.848000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.794200E-01
Normal-vs-N1
5.734800E-01
N0-vs-N1
2.056200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.255000E-01
Normal-vs-TP53-NonMutant
6.564200E-01
TP53-Mutant-vs-TP53-NonMutant
8.304400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
